The group’s initial objective was to enhance the therapy of ovarian carcinoma. The AGO Study Group has been established in 1993 as a non-profit organisation under the original name ‘AGO Studiengruppe Ovarialkarzinom (AGO-OVAR)’.
Imprint
AGO Research GmbH
Kaiser-Friedrich-Ring 71
65185 Wiesbaden
Deutschland
Vertreten durch:
Managing Director: Stefanie Barth
Registered Seat: Kaiser-Friedrich-Ring 71, 65185 Wiesbaden
Kontakt:
Fon: +49 611 880467-0
Fax: +49 611 880467-67
E-Mail: webmaster@ago-ovar.de
Registereintrag:
County Court Wiesbaden HRB 24129
Umsatzsteuer-ID:
UVAT identification number DE 264466146
Copyright information
Layout, texts, images and graphics on this page are protected by law. This applies in particular to brand and patent rights, but also to all other forms of intellectual property rights. Reproduction and / or distribution of individual contents of these pages in whole or in part and / or of complete pages are strictly forbidden. Any violation will be prosecuted to the fullest extent of the civil and / or criminal law.